2026 CPHI Worldwide Pharmaceutical Ingredients Exhibition, South Korea

The 2026 CPHI Korea World Pharmaceutical Ingredients Exhibition is one of the leading pharmaceutical industry events in the CPHI series, focusing on pharmaceutical ingredients, intermediates, contract manufacturing, biopharmaceuticals, pharmaceutical machinery and equipment, and packaging solutions in Korea and the Asian region. The CPHI brand enjoys a global reputation with over 30 years of history, and its exhibitions span major pharmaceutical markets in Europe, Asia, and America, attracting tens of thousands of industry professionals annually. CPHI Korea, as a crucial part of its Asian strategic layout, has rapidly developed into the most influential professional pharmaceutical exhibition in Korea and Northeast Asia since its inception. Held annually in Seoul, Korea, it provides an efficient platform for communication and cooperation for exhibitors and visitors, thanks to its international perspective and localized depth. The exhibition's scale has expanded year by year, with a continuous increase in the number of exhibiting companies and professional visitors, including pharmaceutical ingredient suppliers, pharmaceutical equipment manufacturers, contract development and manufacturing organizations (CDMO/CMO), biopharmaceutical companies, packaging material suppliers, and related service providers from around the world. During the exhibition, in addition to a rich display of exhibits, a series of high-level seminars, technical forums, and business matchmaking events are held, inviting industry experts to share the latest market trends, technological innovations, and regulatory policies, providing valuable learning and networking opportunities for attendees. CPHI Korea is not only an important window for showcasing new products and technologies but also a key platform for promoting industry cooperation, expanding international markets, and grasping the pulse of Asia's pharmaceutical industry development. It holds irreplaceable strategic significance for companies wishing to enter or deepen their presence in the Korean and Asian pharmaceutical markets.

The exhibit range of the 2026 CPHI Korea World Pharmaceutical Ingredients Exhibition covers all aspects of the pharmaceutical industry chain, aiming to provide a one-stop solution for the global pharmaceutical industry. Key exhibit categories include: 1. Pharmaceutical Ingredients (APIs & Intermediates): This is the core part of the exhibition, showcasing various active pharmaceutical ingredients (APIs), including chemical synthesis APIs, natural extract APIs, biotechnology APIs, etc. It also covers various pharmaceutical intermediates, fine chemicals, pharmaceutical excipients (e.g., fillers, binders, disintegrants, lubricants, coating materials), medicinal gelatin, capsules, natural extracts, and functional food ingredients. These raw materials are the foundation of drug production, and their quality and innovation directly impact the efficacy and safety of the final product. 2. Contract Services: This area focuses on services provided by Contract Development and Manufacturing Organizations (CDMO/CMO), including drug discovery, preclinical research, clinical trials, formulation development, process optimization, analytical testing, quality control, regulatory submission, and commercial manufacturing. It covers customized services for various drug forms such as small molecule drugs, large molecule biologics, gene therapy, cell therapy, providing flexible and efficient external cooperation solutions for pharmaceutical companies. 3. Biopharmaceuticals: With the development of biotechnology, biopharmaceuticals have become an industry hot spot. This exhibition area will showcase the R&D and production technologies and equipment for biotechnological drugs (e.g., monoclonal antibodies, recombinant proteins, vaccines, gene therapy products), as well as related biological raw materials, cell culture media, bioreactors, purification equipment, etc. It also includes the development and production of biosimilars and biobetters. 4. Pharmaceutical Machinery & Equipment: Covers various advanced machinery and equipment required for drug production, such as formulation equipment (tablet presses, capsule filling machines, coating machines, lyophilizers, filling machines, sterilization equipment), extraction equipment, separation equipment, mixing equipment, crushing equipment, drying equipment, testing equipment, laboratory instruments, cleanroom equipment, water treatment systems, air purification systems, and automated control systems, aiming to improve production efficiency and product quality. 5. Packaging Solutions (Packaging & Drug Delivery): Showcases various pharmaceutical packaging materials and packaging technologies, including glass bottles, plastic bottles, ampoules, vials, pre-filled syringes, blister packaging, aluminum-plastic sheets, pharmaceutical films, labels, anti-counterfeiting packaging, smart packaging, child-resistant packaging, etc. It also includes drug delivery systems (e.g., inhalers, transdermal patches, sustained-release formulations) and related packaging equipment and printing technologies. 6. Laboratory Equipment & Services: Includes various laboratory analytical instruments, testing equipment, consumables, reagents, reference standards, as well as CRO (Contract Research Organization) services such as preclinical and clinical research services, data management, statistical analysis, etc., providing comprehensive support for drug R&D and quality control. 7. Cleanroom Technology & Environmental Control: Showcases cleanroom design and construction, HVAC systems, air filters, microbial control, personnel purification equipment, environmental monitoring systems, etc., ensuring drug production complies with GMP standards.

No fee information available. Please contact us for a quote.